A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.

NCT00495118 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

314

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: risperidone

Sponsor

Janssen, LP